Effect of Two Iron Preparations on Protein in the Urine

Watson Pharmaceuticals12 enrolled

Overview

This pilot study will compare the effects of sodium ferric gluconate complex and iron sucrose on urine concentrations of various chemicals including protein

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Kidney Failure, Chronic Anemia, Iron-Deficiency

Interventions

Sodium Ferric Gluconate and Iron sucroseDRUG

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Moderate to severe anemia * Iron deficiency * Moderate to severe chronic kidney disease * Age ≥ 18 or greater and able to give informed consent Exclusion Criteria: * Receiving dialysis * Known sensitivity to Sodium Ferric Gluconate Complex in Sucrose Injection, Iron sucrose USP, or any of their components * Clinically unstable * Indication of iron sufficiency

Locations (2)

Unnamed facility

Glendale, California, United States

Unnamed facility

Shreveport, Louisiana, United States

Outcomes

Primary Outcomes

Change in urine protein

Time frame: 180 minutes

Secondary Outcomes

Change in various urine chemicals

Time frame: 180 minutes

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.